Siami, Paul F., M.D. Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2005
NCT00701779
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

dutasteride (avodart) (1 trial)

tamsulosin (flomax) (1 trial)

tolterodine (detrol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperplasia (Phase 4)

Lower Urinary Tract Symptoms (Phase 4)

Prostatic Hyperplasia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3